Scope The aim of these guidelines is to provide evidence-based recommendations for the
assessment and management of individuals with persistent symptoms after acute COVID-19 …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions
worldwide with a high mortality rate due to a lack of definitive treatment. Despite having a …

Patients with coronavirus disease 2019 (COVID-19) usually suffer from post-acute sequelae
of coronavirus disease 2019 (PASC). Pulmonary fibrosis (PF) has the most significant long …

Long-lasting coronavirus disease 2019 (COVID-19) symptoms beyond 12 weeks, the so-
called 'long COVID'have been increasingly reported worldwide. Long COVID can be …

Background: Pulmonary Rehabilitation (PR) was initially developed for the management of
Chronic Obstructive Pulmonary Disease (COPD) and is now recognized as a core …

Multi-disciplinary collaborative consensus guidance statement on the assessment and
treatment of breathing discomfort and respiratory sequelae in patients with post-acute sequelae …

We have been experiencing multiple waves of the coronavirus disease 2019 (COVID-19)
pandemic. With these unprecedented waves, we have entered into an era of 'new normal' …

Objectives This systematic review and meta‐analysis aims to evaluate the efficacy of
pulmonary rehabilitation (PR) in improving dyspnea, fatigue, physical activity, quality of life …

Introduction Long-COVID is a condition characterized by the permanence of symptoms
beyond 4 weeks after an initial infection. It affects 1 out of 5 people and is loosely related to …

In real practice, there is a paradox in the management of patients with 'long-term Covid-
19.'Indeed, Family physicians (FPs) are on the front line in the management process of these …